You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-interventional Study on Salvage Auto in Relapsed Myeloma

Completed
  • Relapsed Multiple Myeloma
    • Paris, France
      Hématologie Clinique, Hôpital Saint Antoine
    Jan 19, 2021

    Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

    Completed
    Has Results
    • Multiple Myeloma
    • Stanford, California
      Stanford University
    Aug 17, 2022

    Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)

    Recruiting
    • Multiple Myeloma
    • Lenalidomide maintenance
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Aug 10, 2022

    Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),

    Not yet recruiting
    • Multiple Myeloma
    • Allogeneic Stem Cells
    • +8 more
    • Freiburg, Baden-Württemberg, Germany
    • +31 more
    Jan 5, 2023

    Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

    Recruiting
    • Multiple Myeloma
    • Autologous hematopoietic stem cell transplantation
    • C-CAR088
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 21, 2022

    Multiple Myeloma Trial in Atlanta (BeEAM)

    Completed
    • Multiple Myeloma
    • Atlanta, Georgia
      Blood and Marrow Transplant Group of Georgia
    Oct 19, 2022

    Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

    Not yet recruiting
    • Lymphoma
    • Peripheral Blood Stem Cell Transplantation
    • Eltrombopag olamine
    • (no location specified)
    Jul 25, 2023

    Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

    Terminated
    Has Results
    • Multiple Myeloma
    • New York, New York
    • +1 more
    Oct 3, 2022

    Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

    Completed
    Has Results
    • Diffuse Large Cell Lymphoma Relapsed/Refractory
    • San Francisco, California
      University of California, San Francisco
    Jun 5, 2022

    Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Hamburg, Germany
    • +3 more
    Dec 16, 2022

    Myeloma Trial in Chicago (drug, procedure, device)

    Active, not recruiting
    • Myeloma
    • Chicago, Illinois
      University of Chicago
    Sep 14, 2021

    Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

    Active, not recruiting
    • Multiple Myeloma
    • CT-011
    • Dendritic Cell Fusion Vaccine
    • Boston, Massachusetts
    • +2 more
    Sep 5, 2022

    Multiple Myeloma in Relapse Trial in Denver, Saint Louis, Toronto (Elotuzumab, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma in Relapse
    • Denver, Colorado
    • +2 more
    Oct 14, 2021

    Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

    Completed
    • Multiple Myeloma
    • Edmonton, Alberta, Canada
    • +9 more
    Sep 20, 2022

    Multiple Myeloma Trial in Lanzhou (Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Lanzhou, Gansu, China
      The First Hospital of Lanzhou University
    Jul 9, 2022

    Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
      John Theurer Cancer Center-Hackensack Meridian Health
    Jan 18, 2022

    Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Carfilzomib Lenalidomide Dexamethasone
    • Isatuximab Carfilzomib Lenalidomide Dexamethasone
    • Ostrava, Czechia
    • +6 more
    Jul 26, 2022

    Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

    Active, not recruiting
    • Multiple Myeloma
    • Auto Stem Cell Transplant
    • Hackensack, New Jersey
      John Theurer Cancer Center @ Hackensack University Medical Cente
    Dec 23, 2022

    Relapsed Multiple Myeloma Trial in Italy (Isatuximab-dexamethasone)

    Active, not recruiting
    • Relapsed Multiple Myeloma
    • Ancona, Italy
    • +14 more
    Mar 24, 2022

    Relapsed or Refractory Hodgkin's Lymphoma Trial in Italy (Atezolizumab, BEGEV)

    Not yet recruiting
    • Relapsed or Refractory Hodgkin's Lymphoma
    • Candiolo, Turin, Italy
    • +18 more
    Mar 17, 2022

    Multiple Myeloma Trial in Suzhou (Tocilizumab)

    Recruiting
    • Multiple Myeloma
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    May 3, 2023

    Fluoroquinolone Resistance Prevalence Study

    Recruiting
    • Multiple Myeloma
      • Washington, District of Columbia
      • +1 more
      Apr 10, 2023

      Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

      Active, not recruiting
      • Multiple Myeloma
      • High-Risk Cancer
      • Bortezomib following nonmyeloablative allogeneic transplant
      • Montreal, Quebec, Canada
        Hôpital Maisonneuve-Rosemont
      Aug 22, 2022